This site is intended for healthcare professionals only
LoginRegister
Zydus-owned Sentynls Menkes disease drug NDA resubmission accepted by USFDAZydus Lifesciences Secures CDSCO Panel Approval for Usnoflast Capsule Interaction Study
Unichem Labs Slapped Rs 1.77 Crore NPPA Notice for Alleged Overpricing of 3 DrugsUnichem Labs Slapped Rs 1.77 Crore NPPA Notice for Alleged Overpricing of 3 Drugs
Sresan Pharmas Coldrif Syrup Banned After 48.6% Toxic Diethylene Glycol DetectedSresan Pharma's Coldrif Syrup Banned After 48.6% Toxic Diethylene Glycol Detected
MSD Pharma Gets Conditional SEC Approval to Begin Phase III Trial of Sacituzumab TirumotecanCDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm
pharmacist suspendedPharmacist Suspended, New Dispensing Guidelines Issued in Rajasthan Amid Cough Syrup Row
700 Cough Syrup Units Audited as Govt Acts on Child Deaths, Substandard Drugs: MoSDoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&D
Bajaj Healthcare appoints Shreekumar Shankarnarayan Nair as Chief Operating OfficerCDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of insomnia drug Suvorexant
medical students suspendedCough Syrup crisis: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma...
AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumoursAstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours
Lupin unveils Liraglutide Injection in US for diabetesLupin unveils Liraglutide Injection in US for diabetes
Police Have No Jurisdiction to Register FIR Under Drugs & Cosmetics Act: Delhi HCPolice Have No Jurisdiction to Register FIR Under Drugs & Cosmetics Act: Delhi HC
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in IndiaMSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India
X